Skip to content
The Nexus
DossierENTITY

The Philadelphia Inquirer

Coverage of The Philadelphia Inquirer in the Nexus archive.

Earliest in view: Apr 23 · 08:55 UTCMost recent: May 19 · 09:00 UTC
Co-mentioned in this coverage
Recent coverage
  • POLITICSMay 19 · 09:00 UTCPROPUBLICA
    With a Chance at Freedom, They Faced an Unexpected Obstacle: Their Own Lawyers

    Milique Wagner spent over a decade in prison fighting his murder conviction, but faced opposition from his own lawyer, who failed to investigate key evidence and instead urged the judge to shut down his petition. Wagner's case is one of many in which court-appointed attorneys did minimal work, delaying or denying justice for wrongfully convicted people. An investigation by The Philadelphia Inquirer and ProPublica found that Philadelphia's post-conviction system repeatedly failed to deliver justice.

  • HEALTHApr 23 · 09:00 UTCPROPUBLICA
    “A Punch in the Gut”: After Years of Waiting, Many Opioid Victims Will Be Shut Out of Purdue Settlement

    Purdue Pharma's $7.4 billion bankruptcy plan, approved in 2024, excludes tens of thousands of opioid victims who originally filed claims, including Mary Jannotta and her family, whose son died from an overdose. The new settlement slashes payments, imposes stricter eligibility requirements, and removes the option to use sworn affidavits to prove Purdue drug use, impacting victims like those who lost loved ones to overdoses.

  • BUSINESSApr 23 · 08:55 UTCPROPUBLICA
    Are You Waiting for Opioid Settlement Money From Purdue, Mallinckrodt or Endo? Get in Touch.

    ProPublica and The Philadelphia Inquirer are investigating how opioid victims have been compensated by trusts funded by Purdue, Mallinckrodt, and Endo. The article seeks input from individuals seeking payment for harm caused by these companies' drugs.

The Philadelphia Inquirer · Dossier · The Nexus